Children in the US feel mixed emotions daily: Social media is a likely enabler. We explore how healthcare providers and marketers can step up to educate youths and their parents.
Another employer gets sued for driving up workers’ Rx costs: But it’s the pharmacy benefit managers that really should be held accountable. Here’s why.
Gen Zers’ and millennials’ patient experience leaves a lot to be desired: Not adapting to younger patients’ expectations could spell trouble for healthcare providers.
Teladoc’s mental health business fails to deliver in Q2: We explore what went wrong with BetterHelp and examine how Teladoc plans to right the ship.
Flo Health raises $200M: The period- and pregnancy-tracking app was at a crossroads just a few years ago. We explore how it came out on the other side stronger than ever.
The most important pharmacy trends of 2024: We explore where consumers fill their prescriptions and examine how online players can gain market share.
Google terminates enterprise contract with One Medical: It’s another setback for One Medical since Amazon took ownership. We explore how it could affect Amazon’s go-forward strategy for its primary care business.
Northwell enters uncharted healthcare marketing territory with a studio division: Launching an entertainment business is a risky bet for a health system. Here’s why.
Healthcare organizations are moving slow with genAI tools: They’re concerned with the tech’s risks and unclear industry regulations. Here’s what it means for AI developers.
Walmart is expanding its specialty pharmacy presence: With a multi-billion dollar market opportunity in-play, its decision to open 25 new autoimmune-focused specialty pharmacies across the US is smart business.
CVS Caremark to pay $45M to Illinois in PBM settlement: While it may seem like the walls are finally closing in on PBMs, paying multi-million dollar settlements is just part of doing business for pharma’s middlemen.
New GLP-1 users are more likely to have obesity than diabetes: The trend is concerning for some patients, but not for Big Pharma.
Headway’s valuation hits $2.3B after closing its Series D: The startup tackles two big problems in the mental health space. Investors are paying close attention.
Humana’s CenterWell to open senior primary care clinics at Walmart stores: Despite recent headwinds in the retail primary care space, we think CenterWell’s deal with Walmart will prove to be symbiotic.
Mayo Clinic, Epic, Abridge develop genAI tool for nurses: The platform will help relieve nurses’ administrative burden, but they still have concerns about AI in healthcare.
40% of drugs approved in the past decade will be blockbusters: We unpack a new forecast of projected drug sales and explore if forthcoming industry headwinds will be enough to curb revenue growth.
Hims & Hers adds longtime Novo exec to its board: Here’s what the appointment tells us about Hims & Hers’ ambitions in the GLP-1 space.
PwC expects healthcare costs to grow 8% in 2025: Below, we detail the primary drivers and how we expect health insurers to combat them.
Physician burnout is declining: While there’s modest improvement in burnout rates, employers who staff doctors need to make them feel more valued at work.
GCI Group rolls out health influencer marketing service: We unpack the details of the new offering from the healthcare communications agency and explore why it could be positioned to succeed in this increasingly crowded space.